CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 50 filers reported holding CORVUS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 5.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $9,555 | +7.1% | 10,500 | 0.0% | 0.00% | – |
| Q4 2022 | $8,925 | -0.8% | 10,500 | 0.0% | 0.00% | – |
| Q3 2022 | $9,000 | -10.0% | 10,500 | 0.0% | 0.00% | – |
| Q2 2022 | $10,000 | -41.2% | 10,500 | 0.0% | 0.00% | – |
| Q1 2022 | $17,000 | -32.0% | 10,500 | 0.0% | 0.00% | – |
| Q4 2021 | $25,000 | -51.0% | 10,500 | 0.0% | 0.00% | – |
| Q3 2021 | $51,000 | +82.1% | 10,500 | 0.0% | 0.00% | – |
| Q2 2021 | $28,000 | -12.5% | 10,500 | 0.0% | 0.00% | – |
| Q1 2021 | $32,000 | – | 10,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $2,784,274 | 0.93% |
| CHI Advisors LLC | 2,384,402 | $2,026,742 | 0.54% |
| Telemetry Investments, L.L.C. | 390,000 | $332 | 0.52% |
| Orbimed Advisors | 6,943,654 | $5,902,106 | 0.11% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 548,727 | $466,418 | 0.07% |
| BVF INC/IL | 1,370,947 | $1,165,305 | 0.05% |
| JACKSON SQUARE CAPITAL, LLC | 63,773 | $54,207 | 0.03% |
| Artal Group S.A. | 500,000 | $425 | 0.02% |
| Hikari Power Ltd | 49,959 | $42 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 159,300 | $135,405 | 0.00% |